Table 3.
No. (%) | ||
---|---|---|
Clinic 1 (n = 234) | Clinic 2 (n = 275) | |
Age, median [IQR], years | 66.0 [55.0–73.0] | 58.0 [57.0–74.5] |
< 39 | 7 (3.0) | 10 (3.6) |
40-49 | 25 (10.7) | 26 (9.5) |
50-59 | 47 (20.1) | 43 (15.6) |
60-69 | 62 (26.5) | 69 (25.1) |
70-79 | 71 (30.3) | 100 (36.4) |
80+ | 22 (9.4) | 27 (9.8) |
Sex | ||
Male | 86 (36.8) | 137 (49.8) |
Female | 148 (63.2) | 138 (50.2) |
Cancer type | ||
Breast | 109 (46.6) | 80 (29.1) |
Prostate | 42 (17.9) | 61 (22.2) |
Lung | 12 (5.1) | 7 (2.5) |
Colorectal | 6 (2.6) | 19 (6.9) |
Endometrial | 7 (3.0) | 10 (3.6) |
Head and neck | 15 (6.4) | 23 (8.4) |
Melanoma | 12 (5.1) | 12 (4.4) |
Metastatic | 8 (3.4) | 13 (4.7) |
Othera | 23 (9.8) | 50 (18.1) |
aCases that are fewer than 5 (i.e., 1-4) are listed in other category for privacy, which includes anal, appendix, bile duct, bladder, brain, cervical, non-Hodgkin lymphoma, oesophageal, ovarian, pancreatic, stomach